PUBLISHER: Global Industry Analysts, Inc. | PRODUCT CODE: 1784087
PUBLISHER: Global Industry Analysts, Inc. | PRODUCT CODE: 1784087
Global Respiratory Oxygen Delivery Devices Market to Reach US$19.8 Billion by 2030
The global market for Respiratory Oxygen Delivery Devices estimated at US$14.0 Billion in the year 2024, is expected to reach US$19.8 Billion by 2030, growing at a CAGR of 5.9% over the analysis period 2024-2030. Oxygen Masks, one of the segments analyzed in the report, is expected to record a 5.0% CAGR and reach US$5.5 Billion by the end of the analysis period. Growth in the Nasal Cannula segment is estimated at 4.6% CAGR over the analysis period.
The U.S. Market is Estimated at US$3.8 Billion While China is Forecast to Grow at 9.1% CAGR
The Respiratory Oxygen Delivery Devices market in the U.S. is estimated at US$3.8 Billion in the year 2024. China, the world's second largest economy, is forecast to reach a projected market size of US$4.0 Billion by the year 2030 trailing a CAGR of 9.1% over the analysis period 2024-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 3.0% and 5.7% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 3.8% CAGR.
Respiratory oxygen delivery devices have become essential for managing acute and chronic respiratory conditions, including COPD, asthma, and pneumonia. The rising prevalence of respiratory diseases, coupled with aging populations and increasing healthcare accessibility, has fueled demand for high-efficiency oxygen therapy solutions. Hospitals, emergency care units, and home healthcare providers rely on oxygen delivery devices such as nasal cannulas, oxygen masks, and non-invasive ventilators to support patients with breathing difficulties. The surge in demand during the COVID-19 pandemic further highlighted the critical role of oxygen therapy in healthcare systems, leading to increased investment in oxygen supply infrastructure and portable oxygen concentrators.
Advancements in portable oxygen concentrators, high-flow nasal cannulas, and non-invasive ventilation systems have improved the efficiency and convenience of respiratory oxygen therapy. Smart oxygen delivery systems with real-time oxygen saturation monitoring and AI-driven flow adjustments are enhancing patient outcomes. Additionally, miniaturized and battery-powered oxygen concentrators are providing greater mobility for patients requiring long-term oxygen therapy. Innovations in humidified oxygen therapy have also improved patient comfort, reducing nasal dryness and irritation. These technological improvements are making respiratory oxygen delivery more accessible, efficient, and patient-friendly.
The increasing preference for home-based respiratory care has driven demand for portable oxygen devices, reducing dependence on hospital-based oxygen therapy. Additionally, the rise of telemedicine and remote patient monitoring has enhanced the management of chronic respiratory conditions, enabling real-time oxygen therapy adjustments. The integration of digital health solutions with oxygen delivery devices is also improving patient compliance and treatment efficacy. Furthermore, the expansion of healthcare infrastructure in developing regions has increased the availability of oxygen therapy in underserved areas.
The growth in the global respiratory oxygen delivery devices market is driven by rising respiratory disease prevalence, advancements in oxygen therapy technology, and increasing demand for portable and home-based oxygen solutions. Government initiatives aimed at improving healthcare access and oxygen supply chains have further supported market expansion. Additionally, the development of smart respiratory devices with AI-based monitoring capabilities is enhancing treatment personalization. As global healthcare systems continue to prioritize respiratory health, the market for oxygen delivery devices is expected to experience sustained growth, driven by ongoing innovation and expanding healthcare accessibility.
SCOPE OF STUDY:
The report analyzes the Respiratory Oxygen Delivery Devices market in terms of units by the following Segments, and Geographic Regions/Countries:
Segments:
Product (Oxygen Masks, Nasal Cannula, Venturi Masks, Non-rebreather Masks, Bag Valve Masks, CPAP Masks, Others); End-Use (Hospitals, Outpatient Facilities, Home Care)
Geographic Regions/Countries:
World; United States; Canada; Japan; China; Europe (France; Germany; Italy; United Kingdom; Spain; Russia; and Rest of Europe); Asia-Pacific (Australia; India; South Korea; and Rest of Asia-Pacific); Latin America (Argentina; Brazil; Mexico; and Rest of Latin America); Middle East (Iran; Israel; Saudi Arabia; United Arab Emirates; and Rest of Middle East); and Africa.
Select Competitors (Total 34 Featured) -
AI INTEGRATIONS
We're transforming market and competitive intelligence with validated expert content and AI tools.
Instead of following the general norm of querying LLMs and Industry-specific SLMs, we built repositories of content curated from domain experts worldwide including video transcripts, blogs, search engines research, and massive amounts of enterprise, product/service, and market data.
TARIFF IMPACT FACTOR
Our new release incorporates impact of tariffs on geographical markets as we predict a shift in competitiveness of companies based on HQ country, manufacturing base, exports and imports (finished goods and OEM). This intricate and multifaceted market reality will impact competitors by increasing the Cost of Goods Sold (COGS), reducing profitability, reconfiguring supply chains, amongst other micro and macro market dynamics.